amarininvestor, I may be wrong, but I believe the label has to be the same per FDA regulations, this is why I stated they would be infringing. As you quoted:
In 2011 the FDA required Teva to amend its carvedilol
label to be “identical in content to the approved [GSK
Coreg®] labeling (including the package insert and any
patient package insert and/or Medication Guide that may
be required).” Dist. Ct. Op. at 587. Teva amended its label
to include the indication for treatment of heart failure, as
required by the FDA. Dist. Ct. Op. at 587.